F.D.A. Approves A.L.S. Treatment Despite Questions About Effectiveness

The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.

View original article
Contributor: Pam Belluck